Nontoxic antimicrobials that evade drug resistance
Drugs that act more promiscuously provide fewer routes for the emergence of resistant mutants. This benefit, however, often comes at the cost of serious off-target and dose-limiting toxicities. The classic example is the antifungal amphotericin B (AmB), which has evaded resistance for more than half...
Main Authors: | Davis, Stephen A, Endo, Matthew M, Whitesell, Luke, Marchillo, Karen, Andes, David R, Burke, Martin D, Vincent, Benjamin Matteson, Lindquist, Susan |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Nature Publishing Group
2016
|
Online Access: | http://hdl.handle.net/1721.1/105472 https://orcid.org/0000-0003-1307-882X |
Similar Items
-
Fitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
by: Vincent, Benjamin Matteson, et al.
Published: (2013) -
A Fungal-Selective Cytochrome bc₁ Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance
by: Srinivas, Raja, et al.
Published: (2017) -
Exploiting fitness trade-offs to prevent antifungal drug resistance
by: Vincent, Benjamin Matteson
Published: (2015) -
Nontoxic antimicrobial cationic peptide nanoconstructs with bacteria-displaceable polymeric counteranions
by: Pranantyo, Dicky, et al.
Published: (2021) -
Nontoxic colloidal particles impede antibiotic resistance of swarming bacteria by disrupting collective motion and speed
by: Lu, Shengtao, et al.
Published: (2016)